Rank | Gene Set | Z-score |
---|---|---|
1 | daunorubicin metabolic process (GO:0044597) | 6.35505831 |
2 | polyketide metabolic process (GO:0030638) | 6.35505831 |
3 | doxorubicin metabolic process (GO:0044598) | 6.35505831 |
4 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.70317973 |
5 | opioid receptor signaling pathway (GO:0038003) | 5.23896935 |
6 | low-density lipoprotein particle clearance (GO:0034383) | 5.13973826 |
7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.68695466 |
8 | regulation of somitogenesis (GO:0014807) | 4.47604311 |
9 | pyrimidine-containing compound salvage (GO:0008655) | 4.35706816 |
10 | pyrimidine nucleoside salvage (GO:0043097) | 4.35706816 |
11 | response to peptidoglycan (GO:0032494) | 4.27827521 |
12 | pentose-phosphate shunt (GO:0006098) | 4.11909793 |
13 | nucleoside salvage (GO:0043174) | 3.94175370 |
14 | neuronal action potential propagation (GO:0019227) | 3.82167245 |
15 | nucleotide salvage (GO:0043173) | 3.78837717 |
16 | NADPH regeneration (GO:0006740) | 3.75838647 |
17 | neutrophil activation involved in immune response (GO:0002283) | 3.71890359 |
18 | membrane raft organization (GO:0031579) | 3.69732408 |
19 | glycoside metabolic process (GO:0016137) | 3.69190042 |
20 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.68849713 |
21 | urinary tract smooth muscle contraction (GO:0014848) | 3.64219233 |
22 | xenobiotic catabolic process (GO:0042178) | 3.57517017 |
23 | pinocytosis (GO:0006907) | 3.55783401 |
24 | positive regulation of vesicle fusion (GO:0031340) | 3.54918260 |
25 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 3.49217053 |
26 | glycosphingolipid catabolic process (GO:0046479) | 3.45685342 |
27 | diaphragm development (GO:0060539) | 3.45403810 |
28 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.34829529 |
29 | negative regulation of metanephros development (GO:0072217) | 3.32486879 |
30 | purine nucleotide salvage (GO:0032261) | 3.28740015 |
31 | regulation of germinal center formation (GO:0002634) | 3.25692143 |
32 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 3.24796594 |
33 | response to pheromone (GO:0019236) | 3.24037284 |
34 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.23639433 |
35 | triglyceride catabolic process (GO:0019433) | 3.23167448 |
36 | cell adhesion mediated by integrin (GO:0033627) | 3.21590658 |
37 | cyclooxygenase pathway (GO:0019371) | 3.20310559 |
38 | protein retention in ER lumen (GO:0006621) | 3.19001193 |
39 | progesterone metabolic process (GO:0042448) | 3.16454051 |
40 | relaxation of cardiac muscle (GO:0055119) | 3.16056031 |
41 | skeletal muscle organ development (GO:0060538) | 3.15382222 |
42 | skeletal muscle fiber development (GO:0048741) | 3.15225224 |
43 | brown fat cell differentiation (GO:0050873) | 3.14931061 |
44 | heart contraction (GO:0060047) | 3.14818841 |
45 | heart process (GO:0003015) | 3.14818841 |
46 | oligosaccharide catabolic process (GO:0009313) | 3.13525548 |
47 | peptidyl-proline hydroxylation (GO:0019511) | 3.11106526 |
48 | mitochondrial genome maintenance (GO:0000002) | 3.10818840 |
49 | protein localization to synapse (GO:0035418) | 3.10246603 |
50 | hyaluronan catabolic process (GO:0030214) | 3.10116738 |
51 | glutamate secretion (GO:0014047) | 3.09760520 |
52 | glycolipid catabolic process (GO:0019377) | 3.09723063 |
53 | acylglycerol catabolic process (GO:0046464) | 3.08385679 |
54 | neutral lipid catabolic process (GO:0046461) | 3.08385679 |
55 | glomerular basement membrane development (GO:0032836) | 3.07334811 |
56 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.07024356 |
57 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.05874269 |
58 | heparin biosynthetic process (GO:0030210) | 3.05647808 |
59 | heparin metabolic process (GO:0030202) | 3.05647808 |
60 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.04808362 |
61 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.04562312 |
62 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.04562312 |
63 | negative regulation of amino acid transport (GO:0051956) | 3.02611980 |
64 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.02522977 |
65 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.01368096 |
66 | regulation of female gonad development (GO:2000194) | 2.99578023 |
67 | positive regulation of male gonad development (GO:2000020) | 2.96715100 |
68 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.94489488 |
69 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.92503243 |
70 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.92475814 |
71 | positive regulation of muscle hypertrophy (GO:0014742) | 2.92475814 |
72 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.91555750 |
73 | white fat cell differentiation (GO:0050872) | 2.87175360 |
74 | glucose catabolic process (GO:0006007) | 2.86200084 |
75 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.85738016 |
76 | behavioral response to cocaine (GO:0048148) | 2.85670088 |
77 | hemoglobin metabolic process (GO:0020027) | 2.85646112 |
78 | retinal metabolic process (GO:0042574) | 2.85642892 |
79 | hemidesmosome assembly (GO:0031581) | 2.85123627 |
80 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.84364530 |
81 | L-phenylalanine metabolic process (GO:0006558) | 2.84364530 |
82 | regulation of vesicle fusion (GO:0031338) | 2.81872416 |
83 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.79675620 |
84 | positive regulation of macrophage cytokine production (GO:0060907) | 2.78477860 |
85 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.77618400 |
86 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.77618400 |
87 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.77578946 |
88 | positive regulation of odontogenesis (GO:0042482) | 2.76018935 |
89 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.75250938 |
90 | negative regulation of interleukin-17 production (GO:0032700) | 2.73923956 |
91 | pentose metabolic process (GO:0019321) | 2.73322374 |
92 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.72853194 |
93 | Peyers patch development (GO:0048541) | 2.72853194 |
94 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.72236596 |
95 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.69050304 |
96 | negative regulation of phagocytosis (GO:0050765) | 2.68880193 |
97 | response to nitrosative stress (GO:0051409) | 2.67025199 |
98 | mature B cell differentiation involved in immune response (GO:0002313) | 2.66806974 |
99 | gamma-aminobutyric acid transport (GO:0015812) | 2.66138152 |
100 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.65384154 |
101 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.64324775 |
102 | neutrophil mediated immunity (GO:0002446) | 2.63929374 |
103 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.63811663 |
104 | regulation of sequestering of triglyceride (GO:0010889) | 2.62962058 |
105 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.62729356 |
106 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.62335632 |
107 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.61899839 |
108 | positive regulation of glomerulus development (GO:0090193) | 2.61149698 |
109 | negative regulation of fibrinolysis (GO:0051918) | 2.59682077 |
110 | synaptic vesicle exocytosis (GO:0016079) | 2.59638286 |
111 | neuron remodeling (GO:0016322) | 2.58950578 |
112 | cellular glucuronidation (GO:0052695) | 2.58767896 |
113 | negative regulation of interleukin-8 production (GO:0032717) | 2.58645658 |
114 | regulation of vitamin metabolic process (GO:0030656) | 2.58532842 |
115 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.57911222 |
116 | protein hydroxylation (GO:0018126) | 2.57440518 |
117 | ceramide catabolic process (GO:0046514) | 2.57307353 |
118 | activation of protein kinase A activity (GO:0034199) | 2.56589073 |
119 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.55611132 |
120 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.55197582 |
121 | positive regulation of tissue remodeling (GO:0034105) | 2.54877365 |
122 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.54145131 |
123 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.53751806 |
124 | positive regulation of axon extension (GO:0045773) | 2.51435546 |
125 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.48910975 |
126 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.48123236 |
127 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.47853531 |
128 | negative regulation of organic acid transport (GO:0032891) | 2.46921691 |
129 | membrane depolarization during action potential (GO:0086010) | 2.46441690 |
130 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.45695304 |
131 | quinone metabolic process (GO:1901661) | 2.45163229 |
132 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.45046506 |
133 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.45024666 |
134 | fibrinolysis (GO:0042730) | 2.44537186 |
135 | valine metabolic process (GO:0006573) | 2.44504405 |
136 | response to vitamin E (GO:0033197) | 2.43498780 |
137 | cardiac myofibril assembly (GO:0055003) | 2.43129282 |
138 | positive regulation of myoblast differentiation (GO:0045663) | 2.43119821 |
139 | lipoprotein transport (GO:0042953) | 2.42883895 |
140 | regulation of mast cell degranulation (GO:0043304) | 2.42184227 |
141 | regulation of skeletal muscle contraction (GO:0014819) | 2.42123206 |
142 | alkaloid metabolic process (GO:0009820) | 2.40997355 |
143 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.40913611 |
144 | positive regulation of mast cell degranulation (GO:0043306) | 2.40893227 |
145 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.40893227 |
146 | uronic acid metabolic process (GO:0006063) | 2.40816480 |
147 | glucuronate metabolic process (GO:0019585) | 2.40816480 |
148 | proline transport (GO:0015824) | 2.40455921 |
149 | positive regulation of DNA recombination (GO:0045911) | 2.40321981 |
150 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.40178983 |
151 | endodermal cell differentiation (GO:0035987) | 2.40032628 |
152 | urea metabolic process (GO:0019627) | 2.39681441 |
153 | fatty acid transmembrane transport (GO:1902001) | 2.37266890 |
154 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.35848932 |
155 | L-phenylalanine catabolic process (GO:0006559) | 2.35848932 |
156 | sphingosine metabolic process (GO:0006670) | 2.35256376 |
157 | relaxation of muscle (GO:0090075) | 2.34795736 |
158 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.34329889 |
159 | short-chain fatty acid metabolic process (GO:0046459) | 2.34187710 |
160 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.33711163 |
161 | regulation of macrophage cytokine production (GO:0010935) | 2.33668841 |
162 | positive regulation of isotype switching (GO:0045830) | 2.32938402 |
163 | positive regulation of leukocyte degranulation (GO:0043302) | 2.32528777 |
164 | response to dietary excess (GO:0002021) | 2.31825213 |
165 | positive regulation of hemostasis (GO:1900048) | 2.31618241 |
166 | positive regulation of blood coagulation (GO:0030194) | 2.31618241 |
167 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.30617872 |
168 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.30188945 |
169 | cornea development in camera-type eye (GO:0061303) | 2.29953007 |
170 | urea cycle (GO:0000050) | 2.29659214 |
171 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.27990763 |
172 | deoxyribose phosphate catabolic process (GO:0046386) | 2.27416140 |
173 | localization within membrane (GO:0051668) | 2.26547079 |
174 | regulation of gonadotropin secretion (GO:0032276) | 2.26312114 |
175 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.26061155 |
176 | positive regulation of interleukin-12 production (GO:0032735) | 2.25815998 |
177 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.24845916 |
178 | positive regulation of coagulation (GO:0050820) | 2.24352796 |
179 | layer formation in cerebral cortex (GO:0021819) | 2.24271173 |
180 | vocalization behavior (GO:0071625) | 2.23988124 |
181 | response to laminar fluid shear stress (GO:0034616) | 2.23218014 |
182 | regulation of leukocyte degranulation (GO:0043300) | 2.22729675 |
183 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.22558358 |
184 | glomerulus development (GO:0032835) | 2.22128141 |
185 | neuron recognition (GO:0008038) | 2.21798142 |
186 | relaxation of smooth muscle (GO:0044557) | 2.21572825 |
187 | regulation of cholesterol storage (GO:0010885) | 2.21500231 |
188 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 2.21251184 |
189 | production of molecular mediator of immune response (GO:0002440) | 2.21093690 |
190 | regulation of metalloenzyme activity (GO:0048552) | 2.20845648 |
191 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.20563022 |
192 | alpha-linolenic acid metabolic process (GO:0036109) | 2.20466110 |
193 | nitrogen cycle metabolic process (GO:0071941) | 2.20295286 |
194 | C21-steroid hormone metabolic process (GO:0008207) | 2.19928344 |
195 | cytidine catabolic process (GO:0006216) | 2.19149377 |
196 | cytidine deamination (GO:0009972) | 2.19149377 |
197 | cytidine metabolic process (GO:0046087) | 2.19149377 |
198 | sleep (GO:0030431) | 2.18281956 |
199 | positive regulation of extracellular matrix organization (GO:1903055) | 2.18064682 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.05289391 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.20120411 |
3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 4.01131679 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.86598547 |
5 | GATA1_22025678_ChIP-Seq_K562_Human | 3.50130732 |
6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.36715647 |
7 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.26930868 |
8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.04718071 |
9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.01170527 |
10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.92379645 |
11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.92215769 |
12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.89339822 |
13 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.89319019 |
14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.51203741 |
15 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.37368573 |
16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.35722040 |
17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.26817595 |
18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.26284708 |
19 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.25375036 |
20 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.21000841 |
21 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.12605895 |
22 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.12571509 |
23 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.11519691 |
24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.06955999 |
25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.06216836 |
26 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.05918491 |
27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.05729678 |
28 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.02812541 |
29 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.02812541 |
30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.02662058 |
31 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.01738539 |
32 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.00366315 |
33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00114123 |
34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.99126420 |
35 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.97725996 |
36 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.97725996 |
37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.92844558 |
38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.89513135 |
39 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.86333906 |
40 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.85669680 |
41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83341918 |
42 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.79922450 |
43 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.78352459 |
44 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.77346571 |
45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.77135383 |
46 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.76938085 |
47 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.76797287 |
48 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.76185337 |
49 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.75397989 |
50 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.73103712 |
51 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.71780728 |
52 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.71530327 |
53 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.70737577 |
54 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.69459665 |
55 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.67051666 |
56 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.65064039 |
57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.64112016 |
58 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.63359118 |
59 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.57868633 |
60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.57156472 |
61 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.55048947 |
62 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.52747473 |
63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.51380379 |
64 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.49742370 |
65 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.49742370 |
66 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.47837652 |
67 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.46354752 |
68 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.45514679 |
69 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43955002 |
70 | FUS_26573619_Chip-Seq_HEK293_Human | 1.41621174 |
71 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.41378886 |
72 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.40817867 |
73 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39366421 |
74 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39254347 |
75 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.38365675 |
76 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.37925305 |
77 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37751790 |
78 | CJUN_26792858_Chip-Seq_BT549_Human | 1.37717837 |
79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.37397571 |
80 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.37155877 |
81 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.34585785 |
82 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.34185637 |
83 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.33275842 |
84 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.33244836 |
85 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.32983953 |
86 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32887020 |
87 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.32449724 |
88 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.31059344 |
89 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.30113041 |
90 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.30012120 |
91 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.29342065 |
92 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28956769 |
93 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.28434064 |
94 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26976232 |
95 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.26644333 |
96 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.26639175 |
97 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.26096959 |
98 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25612926 |
99 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.24982285 |
100 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.23183088 |
101 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.21841942 |
102 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.20557167 |
103 | P300_19829295_ChIP-Seq_ESCs_Human | 1.20108238 |
104 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.19696629 |
105 | AR_25329375_ChIP-Seq_VCAP_Human | 1.19661130 |
106 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19224234 |
107 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.19220971 |
108 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.18845196 |
109 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.18537329 |
110 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18410043 |
111 | ATF3_27146783_Chip-Seq_COLON_Human | 1.17897231 |
112 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.17249241 |
113 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16949066 |
114 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.16494236 |
115 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16460560 |
116 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.13802587 |
117 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.12499698 |
118 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12325013 |
119 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.11594973 |
120 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11517965 |
121 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.11012212 |
122 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.10906151 |
123 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10676583 |
124 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10424437 |
125 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.10003091 |
126 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07709658 |
127 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.07552822 |
128 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.07267561 |
129 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07169076 |
130 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06855229 |
131 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05948622 |
132 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.05856901 |
133 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.05582992 |
134 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.04786021 |
135 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.04236405 |
136 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04162410 |
137 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.04090218 |
138 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.03436130 |
139 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.02920822 |
140 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.02559059 |
141 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01961144 |
142 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.01144137 |
143 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00774108 |
144 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00683302 |
145 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.00269802 |
146 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.00245644 |
147 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.99706490 |
148 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.99341628 |
149 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98532526 |
150 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98474025 |
151 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98052987 |
152 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.97654582 |
153 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97337684 |
154 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97292555 |
155 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97090126 |
156 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.97038561 |
157 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.96976486 |
158 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96879689 |
159 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.96837754 |
160 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.96673813 |
161 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.96673813 |
162 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96653708 |
163 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94764105 |
164 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.94616419 |
165 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.94470990 |
166 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.93463090 |
167 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92898703 |
168 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92412356 |
169 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.92177234 |
170 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.91347087 |
171 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90908597 |
172 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.90508232 |
173 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.90295397 |
174 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.90265651 |
175 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90085442 |
176 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89812665 |
177 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.89610524 |
178 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89459969 |
179 | AR_19668381_ChIP-Seq_PC3_Human | 0.89023469 |
180 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88825338 |
181 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.87882588 |
182 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.87318613 |
183 | KDM2B_26808549_Chip-Seq_REH_Human | 0.87221707 |
184 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.85624600 |
185 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85508394 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.13268726 |
2 | MP0005058_abnormal_lysosome_morphology | 3.93678720 |
3 | MP0009780_abnormal_chondrocyte_physiolo | 3.93292763 |
4 | MP0003806_abnormal_nucleotide_metabolis | 3.41421382 |
5 | MP0002876_abnormal_thyroid_physiology | 2.99398771 |
6 | MP0001501_abnormal_sleep_pattern | 2.96159061 |
7 | MP0006082_CNS_inflammation | 2.92859558 |
8 | MP0008961_abnormal_basal_metabolism | 2.89072772 |
9 | MP0002837_dystrophic_cardiac_calcinosis | 2.87644368 |
10 | MP0009046_muscle_twitch | 2.79978475 |
11 | MP0003191_abnormal_cellular_cholesterol | 2.68570124 |
12 | MP0005670_abnormal_white_adipose | 2.57012005 |
13 | MP0009278_abnormal_bone_marrow | 2.56820508 |
14 | MP0000003_abnormal_adipose_tissue | 2.47987606 |
15 | MP0002148_abnormal_hypersensitivity_rea | 2.46745704 |
16 | MP0003705_abnormal_hypodermis_morpholog | 2.43364877 |
17 | MP0009379_abnormal_foot_pigmentation | 2.34339913 |
18 | MP0000015_abnormal_ear_pigmentation | 2.30285389 |
19 | MP0004270_analgesia | 2.26306062 |
20 | MP0000013_abnormal_adipose_tissue | 2.22708285 |
21 | MP0003303_peritoneal_inflammation | 2.18378208 |
22 | MP0003172_abnormal_lysosome_physiology | 2.17266588 |
23 | MP0009840_abnormal_foam_cell | 2.13076898 |
24 | MP0003075_altered_response_to | 2.09885280 |
25 | MP0002160_abnormal_reproductive_system | 2.04906078 |
26 | MP0008438_abnormal_cutaneous_collagen | 2.04035562 |
27 | MP0003329_amyloid_beta_deposits | 2.02458538 |
28 | MP0001545_abnormal_hematopoietic_system | 2.00601192 |
29 | MP0005397_hematopoietic_system_phenotyp | 2.00601192 |
30 | MP0003646_muscle_fatigue | 1.94276829 |
31 | MP0003879_abnormal_hair_cell | 1.94276167 |
32 | MP0002419_abnormal_innate_immunity | 1.92418802 |
33 | MP0004510_myositis | 1.84422626 |
34 | MP0005023_abnormal_wound_healing | 1.84349021 |
35 | MP0005375_adipose_tissue_phenotype | 1.83254062 |
36 | MP0005464_abnormal_platelet_physiology | 1.83210812 |
37 | MP0005085_abnormal_gallbladder_physiolo | 1.81559718 |
38 | MP0003566_abnormal_cell_adhesion | 1.79758040 |
39 | MP0005451_abnormal_body_composition | 1.79267820 |
40 | MP0009785_altered_susceptibility_to | 1.75867735 |
41 | MP0009697_abnormal_copulation | 1.74824185 |
42 | MP0004272_abnormal_basement_membrane | 1.74255089 |
43 | MP0004130_abnormal_muscle_cell | 1.73052837 |
44 | MP0000858_altered_metastatic_potential | 1.70867016 |
45 | MP0005334_abnormal_fat_pad | 1.65886474 |
46 | MP0003315_abnormal_perineum_morphology | 1.65704224 |
47 | MP0005645_abnormal_hypothalamus_physiol | 1.65064394 |
48 | MP0002971_abnormal_brown_adipose | 1.62543008 |
49 | MP0003950_abnormal_plasma_membrane | 1.62503067 |
50 | MP0003635_abnormal_synaptic_transmissio | 1.62365629 |
51 | MP0008260_abnormal_autophagy | 1.60466888 |
52 | MP0002734_abnormal_mechanical_nocicepti | 1.59784845 |
53 | MP0001853_heart_inflammation | 1.57953594 |
54 | MP0009333_abnormal_splenocyte_physiolog | 1.55592147 |
55 | MP0005666_abnormal_adipose_tissue | 1.53791687 |
56 | MP0002733_abnormal_thermal_nociception | 1.53474613 |
57 | MP0004185_abnormal_adipocyte_glucose | 1.52505653 |
58 | MP0000751_myopathy | 1.50730307 |
59 | MP0002272_abnormal_nervous_system | 1.50557297 |
60 | MP0003880_abnormal_central_pattern | 1.49353691 |
61 | MP0003252_abnormal_bile_duct | 1.49120613 |
62 | MP0005257_abnormal_intraocular_pressure | 1.48948560 |
63 | MP0005165_increased_susceptibility_to | 1.47369906 |
64 | MP0008875_abnormal_xenobiotic_pharmacok | 1.47087828 |
65 | MP0004859_abnormal_synaptic_plasticity | 1.46690589 |
66 | MP0001440_abnormal_grooming_behavior | 1.46038224 |
67 | MP0010386_abnormal_urinary_bladder | 1.45522243 |
68 | MP0003122_maternal_imprinting | 1.42905324 |
69 | MP0010329_abnormal_lipoprotein_level | 1.42490482 |
70 | MP0003183_abnormal_peptide_metabolism | 1.42263079 |
71 | MP0009745_abnormal_behavioral_response | 1.40412206 |
72 | MP0003300_gastrointestinal_ulcer | 1.39189794 |
73 | MP0002972_abnormal_cardiac_muscle | 1.38609102 |
74 | MP0001851_eye_inflammation | 1.35714360 |
75 | MP0003436_decreased_susceptibility_to | 1.32258936 |
76 | MP0001968_abnormal_touch/_nociception | 1.32164356 |
77 | MP0005025_abnormal_response_to | 1.31978745 |
78 | MP0005535_abnormal_body_temperature | 1.31938382 |
79 | MP0001502_abnormal_circadian_rhythm | 1.30929103 |
80 | MP0000749_muscle_degeneration | 1.30600202 |
81 | MP0001542_abnormal_bone_strength | 1.30555235 |
82 | MP0005166_decreased_susceptibility_to | 1.29914485 |
83 | MP0005365_abnormal_bile_salt | 1.29554730 |
84 | MP0000343_altered_response_to | 1.29039059 |
85 | MP0002396_abnormal_hematopoietic_system | 1.28413310 |
86 | MP0003656_abnormal_erythrocyte_physiolo | 1.28044925 |
87 | MP0008469_abnormal_protein_level | 1.27713754 |
88 | MP0003890_abnormal_embryonic-extraembry | 1.26953612 |
89 | MP0005076_abnormal_cell_differentiation | 1.26170459 |
90 | MP0004145_abnormal_muscle_electrophysio | 1.24949772 |
91 | MP0001881_abnormal_mammary_gland | 1.24883423 |
92 | MP0005410_abnormal_fertilization | 1.24343399 |
93 | MP0004264_abnormal_extraembryonic_tissu | 1.22967303 |
94 | MP0002452_abnormal_antigen_presenting | 1.22942230 |
95 | MP0005620_abnormal_muscle_contractility | 1.21999192 |
96 | MP0000604_amyloidosis | 1.21584171 |
97 | MP0002078_abnormal_glucose_homeostasis | 1.20871887 |
98 | MP0002060_abnormal_skin_morphology | 1.20746696 |
99 | MP0005000_abnormal_immune_tolerance | 1.20745340 |
100 | MP0003941_abnormal_skin_development | 1.20499024 |
101 | MP0005197_abnormal_uvea_morphology | 1.20215911 |
102 | MP0002063_abnormal_learning/memory/cond | 1.18160725 |
103 | MP0004883_abnormal_blood_vessel | 1.18112851 |
104 | MP0003186_abnormal_redox_activity | 1.17949307 |
105 | MP0003123_paternal_imprinting | 1.17165699 |
106 | MP0003448_altered_tumor_morphology | 1.17121876 |
107 | MP0002572_abnormal_emotion/affect_behav | 1.16302723 |
108 | MP0002138_abnormal_hepatobiliary_system | 1.16089178 |
109 | MP0002064_seizures | 1.15034193 |
110 | MP0005319_abnormal_enzyme/_coenzyme | 1.13008145 |
111 | MP0004484_altered_response_of | 1.12793867 |
112 | MP0003453_abnormal_keratinocyte_physiol | 1.12696315 |
113 | MP0002909_abnormal_adrenal_gland | 1.12081403 |
114 | MP0009115_abnormal_fat_cell | 1.11914606 |
115 | MP0003828_pulmonary_edema | 1.09646811 |
116 | MP0008877_abnormal_DNA_methylation | 1.08525210 |
117 | MP0002735_abnormal_chemical_nociception | 1.04603179 |
118 | MP0002067_abnormal_sensory_capabilities | 1.04353605 |
119 | MP0009384_cardiac_valve_regurgitation | 1.04254499 |
120 | MP0002089_abnormal_postnatal_growth/wei | 1.04216950 |
121 | MP0002693_abnormal_pancreas_physiology | 1.04168016 |
122 | MP0005385_cardiovascular_system_phenoty | 1.01545859 |
123 | MP0001544_abnormal_cardiovascular_syste | 1.01545859 |
124 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.00025396 |
125 | MP0001764_abnormal_homeostasis | 0.99808512 |
126 | MP0002896_abnormal_bone_mineralization | 0.99055115 |
127 | MP0000681_abnormal_thyroid_gland | 0.98330566 |
128 | MP0001845_abnormal_inflammatory_respons | 0.98203953 |
129 | MP0004924_abnormal_behavior | 0.96477488 |
130 | MP0005386_behavior/neurological_phenoty | 0.96477488 |
131 | MP0005332_abnormal_amino_acid | 0.95963667 |
132 | MP0002970_abnormal_white_adipose | 0.95730679 |
133 | MP0004947_skin_inflammation | 0.95674816 |
134 | MP0003221_abnormal_cardiomyocyte_apopto | 0.94879972 |
135 | MP0003959_abnormal_lean_body | 0.94687184 |
136 | MP0003195_calcinosis | 0.93709450 |
137 | MP0004087_abnormal_muscle_fiber | 0.93417947 |
138 | MP0003724_increased_susceptibility_to | 0.92687458 |
139 | MP0004808_abnormal_hematopoietic_stem | 0.91613072 |
140 | MP0002254_reproductive_system_inflammat | 0.91508042 |
141 | MP0002723_abnormal_immune_serum | 0.91365162 |
142 | MP0000685_abnormal_immune_system | 0.91209543 |
143 | MP0005387_immune_system_phenotype | 0.90996613 |
144 | MP0001790_abnormal_immune_system | 0.90996613 |
145 | MP0006276_abnormal_autonomic_nervous | 0.89634157 |
146 | MP0001819_abnormal_immune_cell | 0.89231251 |
147 | MP0002420_abnormal_adaptive_immunity | 0.89145370 |
148 | MP0003091_abnormal_cell_migration | 0.88449464 |
149 | MP0004233_abnormal_muscle_weight | 0.88427335 |
150 | MP0000639_abnormal_adrenal_gland | 0.88317791 |
151 | MP0000767_abnormal_smooth_muscle | 0.87867610 |
152 | MP0004858_abnormal_nervous_system | 0.87303281 |
153 | MP0002877_abnormal_melanocyte_morpholog | 0.86592169 |
154 | MP0005501_abnormal_skin_physiology | 0.86489137 |
155 | MP0002557_abnormal_social/conspecific_i | 0.86181851 |
156 | MP0001835_abnormal_antigen_presentation | 0.85976904 |
157 | MP0001970_abnormal_pain_threshold | 0.85785358 |
158 | MP0005360_urolithiasis | 0.85116174 |
159 | MP0005408_hypopigmentation | 0.85048721 |
160 | MP0005448_abnormal_energy_balance | 0.84844297 |
161 | MP0008569_lethality_at_weaning | 0.84103768 |
162 | MP0005389_reproductive_system_phenotype | 0.84098726 |
163 | MP0002998_abnormal_bone_remodeling | 0.83999163 |
164 | MP0002118_abnormal_lipid_homeostasis | 0.83603484 |
165 | MP0000490_abnormal_crypts_of | 0.83415953 |
166 | MP0010307_abnormal_tumor_latency | 0.82781743 |
167 | MP0009643_abnormal_urine_homeostasis | 0.82364318 |
168 | MP0005275_abnormal_skin_tensile | 0.82332043 |
169 | MP0001533_abnormal_skeleton_physiology | 0.82037666 |
170 | MP0005452_abnormal_adipose_tissue | 0.81517219 |
171 | MP0005164_abnormal_response_to | 0.81324351 |
172 | MP0009763_increased_sensitivity_to | 0.78244561 |
173 | MP0008873_increased_physiological_sensi | 0.77100318 |
174 | MP0010630_abnormal_cardiac_muscle | 0.76839296 |
175 | MP0000920_abnormal_myelination | 0.76754214 |
176 | MP0010352_gastrointestinal_tract_polyps | 0.75724583 |
177 | MP0005595_abnormal_vascular_smooth | 0.74656343 |
178 | MP0002133_abnormal_respiratory_system | 0.71513122 |
179 | MP0005388_respiratory_system_phenotype | 0.71513122 |
180 | MP0001800_abnormal_humoral_immune | 0.70465830 |
181 | MP0005193_abnormal_anterior_eye | 0.69839964 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Anomalous pulmonary venous return (HP:0010772) | 5.42820899 |
2 | Hyperventilation (HP:0002883) | 5.08005537 |
3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.96190469 |
4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.96190469 |
5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.96190469 |
6 | Abnormality of the pulmonary veins (HP:0011718) | 4.78634926 |
7 | Vacuolated lymphocytes (HP:0001922) | 4.02047690 |
8 | Vertebral compression fractures (HP:0002953) | 3.98176164 |
9 | Dry hair (HP:0011359) | 3.90593445 |
10 | Poor eye contact (HP:0000817) | 3.84610831 |
11 | Inappropriate behavior (HP:0000719) | 3.62450795 |
12 | Gonadal dysgenesis (HP:0000133) | 3.51402182 |
13 | Beaking of vertebral bodies (HP:0004568) | 3.37743437 |
14 | Dysostosis multiplex (HP:0000943) | 3.30029968 |
15 | Protrusio acetabuli (HP:0003179) | 3.15404130 |
16 | Oligomenorrhea (HP:0000876) | 3.07613689 |
17 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.07235013 |
18 | Neuroendocrine neoplasm (HP:0100634) | 3.01485706 |
19 | Right ventricular cardiomyopathy (HP:0011663) | 2.97825377 |
20 | Mediastinal lymphadenopathy (HP:0100721) | 2.96583433 |
21 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.93545380 |
22 | Mucopolysacchariduria (HP:0008155) | 2.93545380 |
23 | Hypercortisolism (HP:0001578) | 2.93359132 |
24 | Disinhibition (HP:0000734) | 2.90587699 |
25 | Epileptiform EEG discharges (HP:0011182) | 2.89392440 |
26 | Impaired social interactions (HP:0000735) | 2.86079185 |
27 | Abnormal social behavior (HP:0012433) | 2.86079185 |
28 | Postural tremor (HP:0002174) | 2.85673966 |
29 | EEG with generalized epileptiform discharges (HP:0011198) | 2.84664691 |
30 | Testicular neoplasm (HP:0010788) | 2.84373597 |
31 | Mesangial abnormality (HP:0001966) | 2.84315458 |
32 | Pheochromocytoma (HP:0002666) | 2.82248390 |
33 | Epileptic encephalopathy (HP:0200134) | 2.81612370 |
34 | Spondylolisthesis (HP:0003302) | 2.78895576 |
35 | Amyloidosis (HP:0011034) | 2.78594607 |
36 | Protruding tongue (HP:0010808) | 2.77867613 |
37 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.76037622 |
38 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.76037622 |
39 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.76037622 |
40 | Hyperglycemia (HP:0003074) | 2.75411163 |
41 | Progressive cerebellar ataxia (HP:0002073) | 2.71488626 |
42 | Diaphragmatic weakness (HP:0009113) | 2.66479608 |
43 | Hypsarrhythmia (HP:0002521) | 2.65262535 |
44 | Loss of speech (HP:0002371) | 2.65129341 |
45 | Abnormality of macrophages (HP:0004311) | 2.63181626 |
46 | Broad-based gait (HP:0002136) | 2.62433151 |
47 | Abnormality of the odontoid process (HP:0003310) | 2.60034725 |
48 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.59864747 |
49 | Abnormality of alanine metabolism (HP:0010916) | 2.59864747 |
50 | Hyperalaninemia (HP:0003348) | 2.59864747 |
51 | Arterial tortuosity (HP:0005116) | 2.59177218 |
52 | Severe visual impairment (HP:0001141) | 2.58528561 |
53 | Myelomeningocele (HP:0002475) | 2.55074452 |
54 | Abnormality of the Achilles tendon (HP:0005109) | 2.54071282 |
55 | Hepatocellular necrosis (HP:0001404) | 2.53784833 |
56 | Thoracic kyphosis (HP:0002942) | 2.52184365 |
57 | Exotropia (HP:0000577) | 2.50427523 |
58 | Asymmetry of the thorax (HP:0001555) | 2.49177452 |
59 | Acrocyanosis (HP:0001063) | 2.48522018 |
60 | Atonic seizures (HP:0010819) | 2.45607717 |
61 | Proximal amyotrophy (HP:0007126) | 2.43088038 |
62 | Inability to walk (HP:0002540) | 2.42474489 |
63 | Focal motor seizures (HP:0011153) | 2.41651669 |
64 | Hypoplastic left heart (HP:0004383) | 2.41353622 |
65 | Progressive microcephaly (HP:0000253) | 2.39456256 |
66 | Fair hair (HP:0002286) | 2.38889600 |
67 | Clumsiness (HP:0002312) | 2.37709389 |
68 | Atrophic scars (HP:0001075) | 2.37621560 |
69 | Pseudobulbar signs (HP:0002200) | 2.37585143 |
70 | Fetal akinesia sequence (HP:0001989) | 2.36733015 |
71 | Ketoacidosis (HP:0001993) | 2.35308853 |
72 | Resting tremor (HP:0002322) | 2.34954300 |
73 | Hepatosplenomegaly (HP:0001433) | 2.34237196 |
74 | Generalized tonic-clonic seizures (HP:0002069) | 2.33832380 |
75 | J-shaped sella turcica (HP:0002680) | 2.32795316 |
76 | Achilles tendon contracture (HP:0001771) | 2.31335149 |
77 | Stridor (HP:0010307) | 2.30414109 |
78 | Cervical subluxation (HP:0003308) | 2.21979233 |
79 | Palpitations (HP:0001962) | 2.21169190 |
80 | Abnormality of the intervertebral disk (HP:0005108) | 2.20035960 |
81 | Shoulder girdle muscle weakness (HP:0003547) | 2.19259854 |
82 | Action tremor (HP:0002345) | 2.18792774 |
83 | Onycholysis (HP:0001806) | 2.17452141 |
84 | Vascular tortuosity (HP:0004948) | 2.17428674 |
85 | Systemic lupus erythematosus (HP:0002725) | 2.16719817 |
86 | Cerebral hemorrhage (HP:0001342) | 2.16160397 |
87 | Absent speech (HP:0001344) | 2.15851206 |
88 | Blue irides (HP:0000635) | 2.15813718 |
89 | Hepatic necrosis (HP:0002605) | 2.15506079 |
90 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.14687630 |
91 | Increased cerebral lipofuscin (HP:0011813) | 2.14373190 |
92 | Prolonged neonatal jaundice (HP:0006579) | 2.13328493 |
93 | Visual hallucinations (HP:0002367) | 2.10501603 |
94 | Premature rupture of membranes (HP:0001788) | 2.10299566 |
95 | Hypoplastic heart (HP:0001961) | 2.09617689 |
96 | Polygenic inheritance (HP:0010982) | 2.09138661 |
97 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.08022325 |
98 | Flat acetabular roof (HP:0003180) | 2.07312341 |
99 | Abnormality of the thoracic spine (HP:0100711) | 2.07004539 |
100 | Hypertriglyceridemia (HP:0002155) | 2.06819951 |
101 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.06583681 |
102 | Patent foramen ovale (HP:0001655) | 2.05279330 |
103 | Orthostatic hypotension (HP:0001278) | 2.04937411 |
104 | Xerostomia (HP:0000217) | 2.03300094 |
105 | Hemivertebrae (HP:0002937) | 2.03062230 |
106 | Absence seizures (HP:0002121) | 2.02392057 |
107 | Lower limb amyotrophy (HP:0007210) | 2.01963404 |
108 | Abnormality of the anterior horn cell (HP:0006802) | 2.01905233 |
109 | Degeneration of anterior horn cells (HP:0002398) | 2.01905233 |
110 | Hypokinesia (HP:0002375) | 2.01539258 |
111 | Sex reversal (HP:0012245) | 2.01492448 |
112 | Abnormal sex determination (HP:0012244) | 2.01492448 |
113 | Abnormal pancreas size (HP:0012094) | 2.00831929 |
114 | Syncope (HP:0001279) | 1.98123431 |
115 | Generalized hypopigmentation of hair (HP:0011358) | 1.97655800 |
116 | Deep venous thrombosis (HP:0002625) | 1.97378885 |
117 | Abnormality of the common coagulation pathway (HP:0010990) | 1.95873305 |
118 | Vascular calcification (HP:0004934) | 1.95665008 |
119 | Long toe (HP:0010511) | 1.95068659 |
120 | Distal upper limb amyotrophy (HP:0007149) | 1.95010368 |
121 | Upper limb amyotrophy (HP:0009129) | 1.95010368 |
122 | Generalized myoclonic seizures (HP:0002123) | 1.94830789 |
123 | Abnormality of the acetabulum (HP:0003170) | 1.92576576 |
124 | Focal seizures (HP:0007359) | 1.91289011 |
125 | Bifid tongue (HP:0010297) | 1.91024755 |
126 | Periodontitis (HP:0000704) | 1.90026689 |
127 | Bone cyst (HP:0012062) | 1.89988367 |
128 | Insulin resistance (HP:0000855) | 1.89951168 |
129 | Hematochezia (HP:0002573) | 1.89682177 |
130 | Cardiovascular calcification (HP:0011915) | 1.89343017 |
131 | Metaphyseal dysplasia (HP:0100255) | 1.89167099 |
132 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.87199878 |
133 | Abnormality of the peritoneum (HP:0002585) | 1.86738268 |
134 | Acanthosis nigricans (HP:0000956) | 1.86253418 |
135 | Cardiomegaly (HP:0001640) | 1.85821525 |
136 | Abnormality of the calf musculature (HP:0001430) | 1.85099526 |
137 | Abnormality of the periventricular white matter (HP:0002518) | 1.84535998 |
138 | Striae distensae (HP:0001065) | 1.84331282 |
139 | Hyperthyroidism (HP:0000836) | 1.83870571 |
140 | Cerebral aneurysm (HP:0004944) | 1.83834549 |
141 | Albinism (HP:0001022) | 1.83634286 |
142 | Milia (HP:0001056) | 1.83280810 |
143 | Papillary thyroid carcinoma (HP:0002895) | 1.82748123 |
144 | Bone pain (HP:0002653) | 1.82599482 |
145 | Intellectual disability, profound (HP:0002187) | 1.82433403 |
146 | Glomerulosclerosis (HP:0000096) | 1.82120319 |
147 | Hypercholesterolemia (HP:0003124) | 1.81425324 |
148 | Multiple lipomas (HP:0001012) | 1.80756145 |
149 | Muscle stiffness (HP:0003552) | 1.80313626 |
150 | Tachypnea (HP:0002789) | 1.79905848 |
151 | Focal segmental glomerulosclerosis (HP:0000097) | 1.79671005 |
152 | Thoracolumbar scoliosis (HP:0002944) | 1.78923771 |
153 | Distal lower limb muscle weakness (HP:0009053) | 1.77901951 |
154 | Fatigue (HP:0012378) | 1.77555538 |
155 | Bulbar palsy (HP:0001283) | 1.75960948 |
156 | Abnormality of the lumbar spine (HP:0100712) | 1.75520233 |
157 | Myokymia (HP:0002411) | 1.75382993 |
158 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.74848288 |
159 | Syringomyelia (HP:0003396) | 1.74644833 |
160 | Spinal cord lesions (HP:0100561) | 1.74644833 |
161 | Thrombocytosis (HP:0001894) | 1.74202427 |
162 | Increased serum ferritin (HP:0003281) | 1.74021010 |
163 | Thyroid carcinoma (HP:0002890) | 1.73083830 |
164 | Hyperphosphatemia (HP:0002905) | 1.72886835 |
165 | Upper motor neuron abnormality (HP:0002127) | 1.72819204 |
166 | Status epilepticus (HP:0002133) | 1.72377189 |
167 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.72091573 |
168 | Hand muscle atrophy (HP:0009130) | 1.71785834 |
169 | Myocardial infarction (HP:0001658) | 1.70668113 |
170 | Abnormality of complement system (HP:0005339) | 1.70561252 |
171 | Vertebral hypoplasia (HP:0008417) | 1.70450138 |
172 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.70450138 |
173 | Neoplasm of head and neck (HP:0012288) | 1.69671840 |
174 | Esophageal neoplasm (HP:0100751) | 1.69671840 |
175 | Weak cry (HP:0001612) | 1.68670257 |
176 | Nausea (HP:0002018) | 1.67983209 |
177 | Hyperammonemia (HP:0001987) | 1.66863623 |
178 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.65668737 |
179 | Cheilitis (HP:0100825) | 1.65404405 |
180 | Recurrent abscess formation (HP:0002722) | 1.65019795 |
181 | Diminished motivation (HP:0000745) | 1.64646816 |
182 | Myoglobinuria (HP:0002913) | 1.64555225 |
183 | Generalized aminoaciduria (HP:0002909) | 1.64507526 |
184 | Conjugated hyperbilirubinemia (HP:0002908) | 1.64503129 |
185 | Increased connective tissue (HP:0009025) | 1.64456148 |
186 | Tinnitus (HP:0000360) | 1.63696279 |
187 | Meningocele (HP:0002435) | 1.62877416 |
188 | Sensorimotor neuropathy (HP:0007141) | 1.61813652 |
189 | Myotonia (HP:0002486) | 1.61398374 |
190 | Mitral stenosis (HP:0001718) | 1.61195023 |
191 | Cupped ribs (HP:0000887) | 1.60957975 |
192 | Osteomalacia (HP:0002749) | 1.60612096 |
193 | Abnormality of the vocal cords (HP:0008777) | 1.57074038 |
194 | Eczematoid dermatitis (HP:0000976) | 1.56709471 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BMPR2 | 3.59234668 |
2 | FLT3 | 3.45224369 |
3 | RIPK1 | 3.31665209 |
4 | NME2 | 3.22855331 |
5 | MAP3K9 | 3.08358647 |
6 | CDK12 | 2.89898858 |
7 | SCYL2 | 2.87779457 |
8 | TRIB3 | 2.81488427 |
9 | RIPK4 | 2.50055650 |
10 | MAP3K13 | 2.48993302 |
11 | ARAF | 2.34700677 |
12 | MAP3K12 | 2.28800174 |
13 | IRAK3 | 2.28511604 |
14 | PRPF4B | 2.20957962 |
15 | LATS2 | 2.19346724 |
16 | TESK1 | 2.13465025 |
17 | MAP3K5 | 2.03226145 |
18 | DAPK2 | 1.96594308 |
19 | PBK | 1.91683573 |
20 | PTK2B | 1.89113796 |
21 | TAOK1 | 1.84105592 |
22 | EPHA4 | 1.80636429 |
23 | PLK2 | 1.78670476 |
24 | SIK1 | 1.74806221 |
25 | CAMKK2 | 1.73187146 |
26 | ERN1 | 1.72462552 |
27 | PIK3CG | 1.65411305 |
28 | MAP2K7 | 1.64630348 |
29 | FRK | 1.61610570 |
30 | CAMKK1 | 1.60027872 |
31 | MAP3K4 | 1.55883932 |
32 | TAOK2 | 1.55575251 |
33 | MAP3K10 | 1.53758906 |
34 | MYLK | 1.53373027 |
35 | MAP4K1 | 1.48801797 |
36 | PAK4 | 1.48652073 |
37 | MAP2K4 | 1.48345837 |
38 | EIF2AK3 | 1.47686635 |
39 | CSF1R | 1.46166679 |
40 | TGFBR2 | 1.45751721 |
41 | BLK | 1.43895271 |
42 | CASK | 1.42923091 |
43 | TBK1 | 1.41566952 |
44 | MET | 1.38307109 |
45 | NTRK1 | 1.32222917 |
46 | ERBB4 | 1.28148336 |
47 | BRAF | 1.26366835 |
48 | ERBB3 | 1.26041257 |
49 | MOS | 1.25261083 |
50 | MAP3K14 | 1.24669273 |
51 | CAMK1D | 1.24344183 |
52 | MINK1 | 1.22209550 |
53 | CCNB1 | 1.21518831 |
54 | TYK2 | 1.20772987 |
55 | MELK | 1.18597063 |
56 | MAP3K11 | 1.18005054 |
57 | EPHA2 | 1.15512779 |
58 | WNK3 | 1.13999589 |
59 | KSR2 | 1.07104703 |
60 | ZAK | 1.06816192 |
61 | MAP3K2 | 1.06626728 |
62 | ZAP70 | 1.04259369 |
63 | JAK3 | 1.02363384 |
64 | PASK | 0.98513384 |
65 | LIMK1 | 0.96836520 |
66 | PDK3 | 0.94205540 |
67 | PDK4 | 0.94205540 |
68 | GRK7 | 0.93155007 |
69 | BRD4 | 0.92051965 |
70 | STK10 | 0.91646246 |
71 | DAPK1 | 0.91225887 |
72 | MAPK13 | 0.91028752 |
73 | MATK | 0.87229774 |
74 | KIT | 0.84327171 |
75 | SIK2 | 0.81680308 |
76 | PAK6 | 0.81592244 |
77 | PDGFRA | 0.80694516 |
78 | MAP3K3 | 0.80501873 |
79 | MUSK | 0.79449044 |
80 | PRKD2 | 0.78946463 |
81 | MAP4K2 | 0.78760479 |
82 | MAP2K1 | 0.77257573 |
83 | DAPK3 | 0.73416954 |
84 | RPS6KA2 | 0.73038033 |
85 | MAP3K6 | 0.70902932 |
86 | CLK1 | 0.70027041 |
87 | KSR1 | 0.69253381 |
88 | EPHB2 | 0.68218742 |
89 | JAK2 | 0.68146695 |
90 | PTK2 | 0.67376055 |
91 | IKBKB | 0.66891924 |
92 | MAPK4 | 0.64886558 |
93 | BCKDK | 0.63919781 |
94 | DDR2 | 0.63843616 |
95 | RAF1 | 0.63350505 |
96 | CDK19 | 0.62421655 |
97 | ROCK1 | 0.60423623 |
98 | RET | 0.59281714 |
99 | CDC42BPA | 0.58940892 |
100 | PRKCD | 0.57735732 |
101 | MAP2K3 | 0.57456276 |
102 | LRRK2 | 0.57252907 |
103 | NEK9 | 0.57124311 |
104 | KDR | 0.56893409 |
105 | TRPM7 | 0.55706505 |
106 | ABL2 | 0.55091385 |
107 | CDC7 | 0.54111054 |
108 | CAMK1G | 0.53927164 |
109 | MAPK12 | 0.53090390 |
110 | NTRK3 | 0.51986051 |
111 | LMTK2 | 0.51677078 |
112 | FER | 0.51646317 |
113 | FGR | 0.49777444 |
114 | RPS6KL1 | 0.49470925 |
115 | RPS6KC1 | 0.49470925 |
116 | CDK8 | 0.48000343 |
117 | GRK6 | 0.47665077 |
118 | NEK1 | 0.46498619 |
119 | MARK1 | 0.46351102 |
120 | SGK1 | 0.45959886 |
121 | MAPKAPK5 | 0.44958326 |
122 | CDK6 | 0.44600549 |
123 | RPS6KB2 | 0.44311589 |
124 | EIF2AK1 | 0.43982735 |
125 | ITK | 0.43812670 |
126 | PIM2 | 0.42543334 |
127 | PRKG2 | 0.41907090 |
128 | MAPK11 | 0.41473820 |
129 | ROCK2 | 0.40841639 |
130 | PTK6 | 0.40336401 |
131 | PRKCG | 0.39429306 |
132 | PDPK1 | 0.39375790 |
133 | PRKCQ | 0.38494262 |
134 | CDK9 | 0.36799247 |
135 | TESK2 | 0.36679590 |
136 | GRK5 | 0.36323864 |
137 | STK38 | 0.35541793 |
138 | MARK3 | 0.35350331 |
139 | PDK1 | 0.35077202 |
140 | FES | 0.34752593 |
141 | DYRK1A | 0.34157013 |
142 | PAK1 | 0.34129997 |
143 | ILK | 0.34110943 |
144 | PLK3 | 0.33932594 |
145 | PKN2 | 0.33530826 |
146 | CDK4 | 0.31651835 |
147 | MAP3K1 | 0.31546920 |
148 | CAMK2A | 0.31455411 |
149 | CDK5 | 0.30558192 |
150 | CDK14 | 0.30004981 |
151 | ABL1 | 0.29257554 |
152 | SYK | 0.27613122 |
153 | TLK1 | 0.26751489 |
154 | MST1R | 0.25110372 |
155 | PDK2 | 0.23479797 |
156 | VRK1 | 0.23304715 |
157 | MAPK7 | 0.22258863 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.49531799 |
2 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 3.24956702 |
3 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 3.14355313 |
4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.67170191 |
5 | Galactose metabolism_Homo sapiens_hsa00052 | 2.66083594 |
6 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.40757740 |
7 | Lysosome_Homo sapiens_hsa04142 | 2.36251387 |
8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.28234416 |
9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.17019826 |
10 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 2.10655980 |
11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.00500609 |
12 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.98669178 |
13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.91704572 |
14 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.90976806 |
15 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.89399218 |
16 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.83446071 |
17 | Long-term potentiation_Homo sapiens_hsa04720 | 1.78973778 |
18 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.76228693 |
19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.74179121 |
20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.73231736 |
21 | Circadian entrainment_Homo sapiens_hsa04713 | 1.70463645 |
22 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.69264170 |
23 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.65754242 |
24 | Asthma_Homo sapiens_hsa05310 | 1.63698965 |
25 | Amoebiasis_Homo sapiens_hsa05146 | 1.61630359 |
26 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.60793313 |
27 | Renin secretion_Homo sapiens_hsa04924 | 1.60061561 |
28 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57964113 |
29 | Long-term depression_Homo sapiens_hsa04730 | 1.50362280 |
30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.49211133 |
31 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.46622071 |
32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.44667717 |
33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.44400407 |
34 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.43684183 |
35 | Pertussis_Homo sapiens_hsa05133 | 1.42090980 |
36 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.41678149 |
37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.41183336 |
38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.40494082 |
39 | Insulin secretion_Homo sapiens_hsa04911 | 1.39794552 |
40 | Cocaine addiction_Homo sapiens_hsa05030 | 1.39073441 |
41 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.36635656 |
42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33960971 |
43 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.31335320 |
44 | Shigellosis_Homo sapiens_hsa05131 | 1.31113955 |
45 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.30646183 |
46 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.28141599 |
47 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.28011316 |
48 | Circadian rhythm_Homo sapiens_hsa04710 | 1.27451671 |
49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.27010609 |
50 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.24507272 |
51 | Salivary secretion_Homo sapiens_hsa04970 | 1.23596329 |
52 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.23511137 |
53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.21290105 |
54 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.20144152 |
55 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.17573652 |
56 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.16710672 |
57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.15370840 |
58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.15228852 |
59 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.14724535 |
60 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.12961734 |
61 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.11053001 |
62 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.09300486 |
63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.09033515 |
64 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.08874828 |
65 | Allograft rejection_Homo sapiens_hsa05330 | 1.07523420 |
66 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.07094812 |
67 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.06807716 |
68 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.06599699 |
69 | Insulin resistance_Homo sapiens_hsa04931 | 1.05836173 |
70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.05027124 |
71 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.04487986 |
72 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04078628 |
73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.02847454 |
74 | Salmonella infection_Homo sapiens_hsa05132 | 1.02675341 |
75 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.02587080 |
76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.02445218 |
77 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.01680037 |
78 | Legionellosis_Homo sapiens_hsa05134 | 1.01052260 |
79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.00837121 |
80 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.98942598 |
81 | Morphine addiction_Homo sapiens_hsa05032 | 0.96759752 |
82 | DNA replication_Homo sapiens_hsa03030 | 0.94449978 |
83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93517486 |
84 | GABAergic synapse_Homo sapiens_hsa04727 | 0.92920857 |
85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92449225 |
86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.92081296 |
87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.91090997 |
88 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.91040592 |
89 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89835146 |
90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89264272 |
91 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.89112708 |
92 | Malaria_Homo sapiens_hsa05144 | 0.86494101 |
93 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.85815392 |
94 | Influenza A_Homo sapiens_hsa05164 | 0.85760257 |
95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85326723 |
96 | Nicotine addiction_Homo sapiens_hsa05033 | 0.85251080 |
97 | Bladder cancer_Homo sapiens_hsa05219 | 0.84256039 |
98 | Phagosome_Homo sapiens_hsa04145 | 0.84092871 |
99 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.83341337 |
100 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.82247512 |
101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81756027 |
102 | Melanogenesis_Homo sapiens_hsa04916 | 0.80921925 |
103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79891326 |
104 | Base excision repair_Homo sapiens_hsa03410 | 0.78069111 |
105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77348659 |
106 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.76035596 |
107 | Gap junction_Homo sapiens_hsa04540 | 0.74957044 |
108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.73772742 |
109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72770461 |
110 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.72156594 |
111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72123591 |
112 | Taste transduction_Homo sapiens_hsa04742 | 0.71378528 |
113 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.71060837 |
114 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70537857 |
115 | Olfactory transduction_Homo sapiens_hsa04740 | 0.69704628 |
116 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.69628030 |
117 | Alzheimers disease_Homo sapiens_hsa05010 | 0.69558802 |
118 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69390435 |
119 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69296958 |
120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68688846 |
121 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.68558903 |
122 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.67672901 |
123 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.66744837 |
124 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65556422 |
125 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.64954269 |
126 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.63386615 |
127 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.62954103 |
128 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59783085 |
129 | Focal adhesion_Homo sapiens_hsa04510 | 0.58954843 |
130 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.58741042 |
131 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57960657 |
132 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57530228 |
133 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56800862 |
134 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.56754810 |
135 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.56359244 |
136 | Carbon metabolism_Homo sapiens_hsa01200 | 0.55760748 |
137 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55585010 |
138 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55241053 |
139 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.54604141 |
140 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.53680664 |
141 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.53111757 |
142 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52888559 |
143 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.52241509 |
144 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.51268277 |
145 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.50672462 |
146 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.50167491 |
147 | Leishmaniasis_Homo sapiens_hsa05140 | 0.49494469 |
148 | Tuberculosis_Homo sapiens_hsa05152 | 0.49297243 |
149 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.49093224 |
150 | Prion diseases_Homo sapiens_hsa05020 | 0.48943676 |
151 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48717048 |
152 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.48704959 |
153 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.48514974 |
154 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47924616 |
155 | Sulfur relay system_Homo sapiens_hsa04122 | 0.47659267 |
156 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47613664 |
157 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47467322 |
158 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47226253 |
159 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.46183257 |
160 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.46032371 |
161 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45478839 |
162 | Peroxisome_Homo sapiens_hsa04146 | 0.45324067 |
163 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.44792021 |
164 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43474426 |
165 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.43220058 |
166 | Parkinsons disease_Homo sapiens_hsa05012 | 0.42227512 |
167 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.41514479 |
168 | Thyroid cancer_Homo sapiens_hsa05216 | 0.41419755 |
169 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39897760 |
170 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.36582616 |
171 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36331600 |
172 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35426348 |
173 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35381886 |